LXEO

LXEO EBITDA Margin

-11650.47%TTM

Period ending:

LXEO FY EBITDA Margin%
LXEO FY EBITDA Margin1064.97%-9939.74%
2020-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

LXEO ebitda margin history

EBITDA as a percentage of revenue. The available annual fiscal periods series contains 6 observations from Dec 31, 2020 to Dec 31, 2025.

Lexeo Therapeutics Inc EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
0%
0%
0%
-8,874.7706%
-3,054.2547%
-884.8602%

Compare ebitda margin

All LXEO financial metrics · LXEO stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.